Showing results (971-980 of 1,002) with videos related to
Sort By:
Pageof 101
Nature Medicine|February 6, 2018
Haploinsufficiency leads to neurodegeneration in C9ORF72 ALS/FTD human induced motor neuronsYingxiao Shi, Shaoyu Lin, Kim A Staats, et al.Transplantation and Cellular Therapy|October 4, 2025
Umbilical Cord Blood Transplantation Provides an Alternative for Patients With Chronic Granulomatous Disease Lacking HLA-Matched Donors: A PIDTC ReportDanielle E Arnold, Jennifer W Leiding, Brent Logan, et al.Bioanalysis|November 19, 2016
2016 White Paper on recent issues in bioanalysis: focus on biomarker assay validation (BAV): (Part 3 - LBA, biomarkers and immunogenicity)Susan Richards, Lakshmi Amaravadi, Renuka Pillutla, et al.The Journal of Allergy and Clinical Immunology|April 11, 2017
Outcome of hematopoietic cell transplantation for DNA double-strand break repair disordersJames Slack, Michael H Albert, Dmitry Balashov, et al.Blood Cancer Journal|May 9, 2025
Outcomes of elderly patients with relapsed refractory multiple myeloma (RRMM) treated with teclistamab: a multicenter study from the U.S. Multiple Myeloma Immunotherapy ConsortiumOren Pasvolsky, Danai Dima, Lei Feng, et al.Blood Cancer Journal|November 28, 2025
The impact of extramedullary and paraskeletal plasmacytomas on treatment outcomes in multiple myeloma treated with teclistamab: U.S. Myeloma Immunotherapy Consortium real-world experienceAimaz Afrough, Danai Dima, Beatrice Razzo, et al.Haematologica|August 18, 2025
The impact of age on survival and excess mortality after autologous hematopoietic cell transplantation in newly diagnosed multiple myeloma patientsShohei Mizuno, Luuk Gras, Laurien G A Baaij, et al.Blood Cancer Discovery|August 8, 2025
Real-World Experience with Teclistamab for Relapsed/Refractory Multiple Myeloma from the US Myeloma Immunotherapy ConsortiumBeatrice M Razzo, Shonali Midha, Andrew J Portuguese, et al.Transplantation and Cellular Therapy|December 26, 2022
An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid LeukemiaMolly C Tokaz, Helen Baldomero, Andrew J Cowan, et al.Blood Cancer Discovery|July 9, 2025
Real-World Experience with Teclistamab for Relapsed/ Refractory Multiple Myeloma from the U.S. Myeloma Immunotherapy ConsortiumBeatrice M Razzo, Shonali Midha, Andrew J Portuguese, et al.Pageof 101